Impel NeuroPharma's Series B Round

Impel NeuroPharma raised a round of funding on September 18, 2015. Investors include 3M New Ventures.

Impel is committed to improving the delivery of CNS therapeutics and is rapidly growing its pipeline of internal products through its INP-101, INP-102 and INP-104 programs. The Company's INP-104 produ…

Articles about Impel NeuroPharma's Series B Round: